REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
RGI-2001 demonstrates enhanced efficacy in skin transplantation and acute Graft-versus-Host disease when combined with low-dose Sirolimus. The combination treatment prolongs graft survival and reduces GvHD mortality, indicating potential as a tolerance induction regimen.